Brief: X4 Pharmaceuticals Set Wholesale Acquisition Cost For XOLREMDI On FY Basis To $496,400 For Patients Above 50 Kgs

X4 Pharmaceuticals

29/04/2024 13:35

April 29 (Reuters) - X4 Pharmaceuticals Inc  XFOR.O :
    * X4 PHARMACEUTICALS INC - SET WHOLESALE ACQUISITION COST
FOR
XOLREMDI ON AN ANNUAL BASIS TO $496,400 FOR PATIENTS GREATER
THAN 50 KILOGRAMS
    * X4 PHARMACEUTICALS INC - SET A WHOLESALE ACQUISITION COST
FOR
XOLREMDI ON AN ANNUAL BASIS TO $372,300 FOR PATIENTS LESS THAN
OR EQUAL TO 50 KILOGRAMS

Source text for Eikon:  ID:n0001628280-24-018793 
Further company coverage:  XFOR.O 

 ((Reuters.Briefs@thomsonreuters.com;))